Clifford J. Bailey
Birmingham, ENG B47ET, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes.
Journal: Peptides
Published: February 01, 2026
Metformin: Antidiabetic actions from cells to tissues.
Journal: Metabolism: clinical and experimental
Published: October 23, 2025
Pharmacological therapies for type 2 diabetes: future approaches.
Journal: Diabetologia
Published: June 24, 2025
Cardiorenal effects of therapies for type 2 diabetes and obesity.
Journal: The British journal of cardiology
Published: October 08, 2024
Diabetes and gout: another role for SGLT2 inhibitors?
Journal: Therapeutic advances in endocrinology and metabolism
Published: May 21, 2024
Metformin: Therapeutic profile in the treatment of type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: March 31, 2024
Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes.
Journal: Peptides
Published: December 16, 2023
Recent advances in peptide-based therapies for obesity and type 2 diabetes.
Journal: Peptides
Published: December 04, 2023
Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future.
Journal: Diabetes technology & therapeutics
Published: June 12, 2023
Prediabetes: never too early to intervene.
Journal: The lancet. Diabetes & endocrinology
Published: May 15, 2023
An update on peptide-based therapies for type 2 diabetes and obesity.
Journal: Peptides
Published: December 02, 2022
Last Updated: 09/26/2026